Kestra Medical Technologies (KMTS) vs LeMaitre Vascular (LMAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kestra Medical Technologies (KMTS) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 8.6% versus a loss of 8.6%. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $1.54 billion), about 1.2 times the size. LeMaitre Vascular pays a dividend yielding 1.13%, while Kestra Medical Technologies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KMTS | LMAT |
|---|---|---|
| Share price | $25.80 | $79.59 |
| Market cap | $1.54B | $1.82B |
| 1-day change | -2.62% | +0.35% |
| YTD return | -0.11% | -2.21% |
| 1-year return | +8.61% | -8.62% |
| 5-year return | — | +48.02% |
| P/E ratio (TTM) | — | 27.92 |
| Forward P/E | — | 25.04 |
| EPS (TTM) | $-2.67 | $2.85 |
| Dividend yield | 0.00% | 1.13% |
| Annual dividend | $0.00 | $0.90 |
| 52-week high | $30.00 | $118.01 |
| 52-week low | $17.34 | $78.22 |
| Distance from 52-week high | -14.02% | -32.56% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +17.43% | +34.45% |
| Average volume | 357.97K | 328.65K |
| Shares outstanding | 59.56M | 22.87M |
| Employees | 443 | 646 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KMTS has outperformed LMAT by 17.2 percentage points over the past year.
- LeMaitre Vascular offers a meaningfully higher dividend yield (1.13% vs 0.00%).
About Kestra Medical Technologies
KMTS stock →Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
Health Care · Medical/Dental Instruments · 443 employees
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 646 employees
KMTS vs LMAT FAQ
Which is bigger, Kestra Medical Technologies or LeMaitre Vascular?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $1.54B for Kestra Medical Technologies (KMTS).
Which stock has performed better over the past year, KMTS or LMAT?
KMTS returned +8.61% over the past 12 months, compared with -8.62% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Kestra Medical Technologies or LeMaitre Vascular?
LeMaitre Vascular pays a dividend yielding 1.13%, while Kestra Medical Technologies does not currently pay a regular dividend.
Are Kestra Medical Technologies and LeMaitre Vascular in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.